CRISPR/CAS as a powerful tool for HIV cure - a review
Shirley Vasconcelos komninakis,Wilson Domingues,Sabri Sanabani,Victor Angelo Folgosi,Igor Neves Barbosa,Jorge Casseb
DOI: https://doi.org/10.1089/aid.2022.0148
2024-01-03
AIDS Research and Human Retroviruses
Abstract:Despite care and the availability of effective antiretroviral treatment, some people living with HIV (PLHIV) suffer from neurocognitive disorders associated with the human immunodeficiency virus (HAND) that is a major problem in their quality of life. The different types of HAND can be characterized into asymptomatic neurocognitive impairment (ANI), mild neurocognitive disorder (MND), and the most severe form known as HIV-associated dementia (HAD). Little is known about the mechanisms of HAND, but it is accepted that it is correlated with the infection of astrocytes, microglial cells and macrophages in the human brain. The formation of a viral reservoir that remains dormant as a provirus in resting CD4+ T lymphocytes, and of refuge tissues, such as the brain is a major contributor to HIV eradication. In recent years, a new set of tools has emerged: gene editing based on the CRISPR/Cas9 system, which can alter genomic segments by insertion, deletion, and replacement and has great therapeutic potential. This technology has been used in research to treat HIV and appears to offer hope for a possible cure for HIV infection and perhaps the prevention of HAND. This approach has the potential to directly impact the quality of life of HIV-infected individuals, which is a very important topic to be known and discussed.
immunology,infectious diseases,virology